MeSH term
Frequency | Condition_Probility | Female | 12 | 0.0 |
Humans | 32 | 0.0 |
Pregnancy | 4 | 0.0 |
Mutation | 3 | 0.0 |
Child | 6 | 0.0 |
Cryptorchidism/*genetics | 6 | 42.0 |
Heterozygote | 3 | 0.0 |
Homozygote | 2 | 0.0 |
Male | 26 | 0.0 |
Polymerase Chain Reaction | 3 | 0.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
Proteins/*genetics | 11 | 0.0 |
Animals | 16 | 0.0 |
Mice | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 21 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 5 | 0.0 |
Signal Transduction | 3 | 0.0 |
Cryptorchidism/*genetics/pathology | 2 | 66.0 |
DNA/genetics | 3 | 0.0 |
Exons | 3 | 0.0 |
*Mutation | 4 | 0.0 |
Testis/pathology | 2 | 4.0 |
United States | 2 | 0.0 |
Adult | 8 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Heteroduplex Analysis | 2 | 2.0 |
Leydig Cells/metabolism | 3 | 21.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Sperm Count | 2 | 3.0 |
Adolescent | 4 | 0.0 |
Child, Preschool | 4 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Molecular Sequence Data | 9 | 0.0 |
Reference Values | 2 | 0.0 |
*Glycoproteins | 2 | 0.0 |
Amino Acid Sequence | 7 | 0.0 |
Middle Aged | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Rats | 3 | 0.0 |
Base Sequence | 4 | 0.0 |
Comparative Study | 2 | 0.0 |
Introns | 2 | 0.0 |
Infant | 2 | 0.0 |
Testis/*metabolism | 2 | 2.0 |
Cell Line | 3 | 0.0 |
Cyclic AMP/metabolism | 2 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Receptors, Peptide/*genetics | 2 | 9.0 |
DNA Primers | 2 | 0.0 |
Exons/genetics | 2 | 0.0 |
DNA, Complementary/biosynthesis/genetics | 2 | 4.0 |
Ligands | 2 | 0.0 |
Reproduction/*physiology | 2 | 7.0 |
